Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Interleukin 8 is a biomarker of telomerase inhibition in cancer cells

Fig. 1

Measurement of response of cancer cells to telomerase inhibition. Indicated cell lines were treated with mismatch oligonucleotide nucleotide or imetelstat for 2 weeks. a Cell viability was monitored by trypan blue exclusion assay and relative cell viability with respect to mismatch oligonucleotide nucleotide treated cell is plotted (b) Telomerase activities was measured by TRAP assay and relative telomerase activity with respect to mismatch oligonucleotide nucleotide treated cell is plotted. Error bar shows Standard Error Mean (SEM). (**, p < 0.001), (ns, non-significant)

Back to article page